These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9204260)

  • 1. Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis.
    Häuselmann HJ
    Curr Opin Rheumatol; 1997 May; 9(3):241-50. PubMed ID: 9204260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present and future therapeutic strategies in rheumatoid arthritis].
    Schacht E
    Z Rheumatol; 1993; 52(6):365-82. PubMed ID: 8147131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines in rheumatoid arthritis: new therapeutic possibilities].
    Szekanecz Z; Szegedi G
    Orv Hetil; 1998 Apr; 139(14):819-23. PubMed ID: 9569729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.
    Bayry J; Sibéril S; Triebel F; Tough DF; Kaveri SV
    Drug Discov Today; 2007 Jul; 12(13-14):548-52. PubMed ID: 17631249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis.
    Nakagawa T; Akagi M; Hoshikawa H; Chen M; Yasuda T; Mukai S; Ohsawa K; Masaki T; Nakamura T; Sawamura T
    Arthritis Rheum; 2002 Sep; 46(9):2486-94. PubMed ID: 12355497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors underlying chronic inflammation in rheumatoid arthritis.
    Wong SH; Lord JM
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):379-88. PubMed ID: 15577739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel model of fibroblast-mediated cartilage destruction.
    Sack U; Hirth A; Funke B; Wiedemeyer K; Lange F; Tröltzsch M; Tannapfel A; Gebhardt R; Emmrich F; Lehmann J
    Scand J Immunol; 2005 Jan; 61(1):18-28. PubMed ID: 15644119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model.
    Müller-Ladner U; Evans CH; Franklin BN; Roberts CR; Gay RE; Robbins PD; Gay S
    Arthritis Rheum; 1999 Mar; 42(3):490-7. PubMed ID: 10088772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Jones RE; Moreland LW
    Bull Rheum Dis; 1999; 48(3):1-4. PubMed ID: 10408141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Joint destruction and its repair in rheumatoid arthritis].
    Kohsaka H
    Clin Calcium; 2009 Mar; 19(3):317-23. PubMed ID: 19252241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.